LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Foot & Ankle/Integra Launches New Ankle System
Foot & Ankle

Integra Launches New Ankle System

May 18, 2016 1 min read Premium comments

Advertisement

Integra Launches New Ankle System
Courtesy of Integra Life Sciences
Secondary

A collaboration of three leading foot and ankle surgeons and Plainsboro, New Jersey-based Integra LifeSciences Holding Corporation has produced the Cadence Total Ankle System which, in the words of one of the surgeons, “will make total ankle replacement easier, quicker and more reproducible for foot and ankle surgeons.”

The three world renowned doctors are Tim Daniels of the University of Toronto, David Pedowitz of the Rothman Institute, and Selene Parekh of Duke University.

Parekh described the new ankle system. “This ankle has incorporated many anatomical considerations into its design. It allows the surgeon to maintain more bone stock, and provides options to correctly align the ankle back to its native location. Finally, we’ve streamlined both the Cadence system’s design and instrumentation so it’s more efficient for the surgeon and surgical team, ” he said.

Pedowitz added, “Ankle replacement is a technically challenging procedure. With the Cadence system, we have pared down the complexity of the instrumentation in an intuitive fashion.”

In 2015, Integra LifeSciences acquired the Salto Talaris and Salto Talaris XT ankle replacement products. Company officials believe that the Cadence systems differentiated anatomic design and streamlined surgical technique will complement the proven clinical history and revision features of the Salto Talaris product line. Integra plans to offer a complete set of options to treat the entire continuum of care of ankles—one of the fastest growing extremities segments.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy